Literature DB >> 3877801

Asbestos-related disease in plumbers and pipefitters employed in building construction.

N L Sprince, L C Oliver, T C McLoud.   

Abstract

Asbestos-related disease in a group of 153 plumbers and pipefitters employed in building construction was assessed by means of a cross-sectional prevalence study. Study methods were medical questionnaire, spirometry, measurement of diffusing capacity, physical examination of the chest, and chest roentgenogram. The major finding was bilateral pleural thickening in 28 (18.3%) of the participants. Unilateral pleural thickening was found in 12 subjects (7.8%). Small irregular opacities of profusion 1/0 or greater were found in 12 subjects (7.8%). Bilateral pleural thickening was associated with both age and time since first asbestos exposure, while unilateral pleural thickening was associated only with age. Decreases in forced vital capacity (percent predicted) were associated with duration of exposure. The most prevalent abnormality found was bilateral pleural thickening, which is more specific for asbestos exposure than is unilateral pleural thickening.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877801

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  4 in total

1.  Respiratory findings among ironworkers: results from a clinical survey in the New York metropolitan area and identification of health hazards from asbestos in place at work.

Authors:  A Fischbein; J C Luo; S Rosenfeld; M Lacher; A Miller; A Rosenbaum
Journal:  Br J Ind Med       Date:  1991-06

2.  Lung health among plumbers and pipefitters in Edmonton, Alberta.

Authors:  P A Hessel; L S Melenka; D Michaelchuk; F A Herbert; R L Cowie
Journal:  Occup Environ Med       Date:  1998-10       Impact factor: 4.402

3.  Measurements of respiratory illness among construction painters.

Authors:  M C White; E L Baker
Journal:  Br J Ind Med       Date:  1988-08

Review 4.  A Review of Pharmacologic Management in the Treatment of Mesothelioma.

Authors:  Eric P Borrelli; Conor G McGladrigan
Journal:  Curr Treat Options Oncol       Date:  2021-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.